A federal judge cited the “alarming” number of drug overdose deaths taking place in New Hampshire in ruling that the state could pursue a lawsuit claiming OxyContin maker Purdue Pharma LP deceptively marketed opioids in state rather than federal court.
U.S. District Judge Paul Barbadoro in Concord, New Hampshire, remanded the case at a hearing in November and on Tuesday issued an opinion explaining why he was rejecting Purdue Pharma’s contention that the federal courts could exercise jurisdiction over the state court lawsuit under the Class Action Fairness Act.
To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2mpcTWn
Our Standards: The Thomson Reuters Trust Principles.